Corvus Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$10.58

+0.85 (+8.74%)

As of Nov 7, 1:45 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +329.1% upside

Low Target $29.32

Average Target $45.40

High Target $54.46

Current Price $10.58

Current
$10.58

Target
$45.40

$29.32 $45.40 avg $54.46

Scenario Analysis

Bear Case

$29.32

177.1%

Low target

Base Case

$45.40

+329.1%

Avg target

Bull Case

$54.46

+414.7%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$26.95

-60.7% from high

52-Week Low

$6.39

+65.6% from low

Target vs 52W High

$45.40

+68.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%